Gregg H. Alton has been named executive vice president, Corporate and Medical Affairs at Gilead Sciences. He was previously senior vice president and general counsel, responsible for legal, government and public affairs and international access operations, and recently assumed the additional responsibility of management for Gilead’s global medical affairs activities and personnel. Mr. Alton will continue to report to John C. Martin, Ph.D., Gilead’s chairman and chief executive officer.

“Gregg has established and built a number of critical functions at Gilead, and in doing so has demonstrated his leadership and his understanding of how every part of our organization contributes to delivering therapies to patients,” said Dr. Martin. “Gregg’s knowledge of public health and health policy will be instrumental to our medical affairs efforts across therapeutic categories. This promotion is recognition of his many contributions to our company and the importance of his continued leadership and vision.”

Mr. Alton joined Gilead Sciences in 1999. From 2000 to 2009 he served as general counsel. Prior to joining Gilead, Mr. Alton was an attorney at the law firm of Cooley Godward, LLP, where he specialized in mergers and acquisitions, corporate partnerships and corporate finance transactions for healthcare and information technology companies.

Sign up today for Contracting & Outsourcing 2009!